Pfizer beats fourth-quarter profit estimates on cost-cutting efforts
U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and ...
Analysts Conflicted on These Healthcare Names: Rezolute (RZLT) and Pfizer (PFE)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rezolute (RZLT – Research Report) and Pfizer (PFE – Research ...
pharmaphorum8d
Pfizer offers $60m to settle prescriber kickback claims
Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary ...
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society ...
Lucia and Heart Rhythm Society Announce Strategic Collaboration to Enhance UpBeat.org for AFib Patients, Sponsored by the BMS-Pfizer Alliance
Lucia, a leader in health AI and patient engagement solutions, and the Heart Rhythm Society (HRS), the international leader ...
Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider
Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.
Business Wire7d
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
Key ASCO GU Presentations Prostate Cancer Bladder Cancer Additional information on key Pfizer-sponsored abstracts at ASCO GU 2025, including date and time of presentation, follow in the chart below.